NCT07015931View on ClinicalTrials.gov

Efficacy, Safety Profile, and Post-Acne Sequelae of 0.025% Retinoic Acid Cream vs. 0.1% Adapalene Cream in Mild Acne Vulgaris in Fitzpatrick Skin Types III-V

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

March 8, 2025

Study Completion Date

March 15, 2025

Conditions

Acne Vulgaris

Interventions

DRUG

retinoic acid cream 0.025%

half finger tip unit

DRUG

adapalene cream 0.1%

half finger tip unit

Trial Locations (1)

10430

Cipto Mangunkusumo National Hospital, Jakarta

All Listed Sponsors

lead

Indonesia University

OTHER

NCT07015931 - Efficacy, Safety Profile, and Post-Acne Sequelae of 0.025% Retinoic Acid Cream vs. 0.1% Adapalene Cream in Mild Acne Vulgaris in Fitzpatrick Skin Types III-V | Biotech Hunter | Biotech Hunter